Interleukin-4 receptor alpha T1432C and A1652G polymorphisms are associated with risk of visceral leishmaniasis

Ahmadi, Alireza; Hajilooi, Mehrdad; Solgi, Ghasem; Abasi, Mohammad; Bazmani, Ahad; Matini, Mohammad; Sardarian, Khosro

Interleukin-4 receptor alpha T1432C and A1652G polymorphisms are associated with risk of visceral leishmaniasis

Authors

¹ Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

² Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

³ Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

⁴ Department of Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Abstract

Background: Immune responses play significant roles in protection against leishmaniasis. Polymorphisms within the interleukin 4 receptor alpha chain (IL-4Rα) gene affect the production of cytokines, which is important for the clearance of many pathogens. The aim of the current study was to identify the relationship between visceral leishmaniasis (VL) infection and polymorphisms at positions T1432C and A1652G of IL-4Rα in an Iranian population.
Materials and Methods: This cross-sectional study was performed during 2004–2012 and included three groups of participants: VL patients (Group 1, n = 124), seropositive healthy controls (Group 2, n = 101), and seronegative healthy controls (Group 3, n = 55). The IL-4Rα T1432C and A1652G polymorphisms were evaluated using a polymerase chain reaction-restriction fragment length polymorphism technique, and anti-Leishmania antibody titers were determined by using immunofluorescence technique. Alleles and genotypes were compared between groups of the study as well as Groups 1 and 2 based on the titer of antibodies. The validity of the data was analyzed using Hardy–Weinberg equilibrium and one-way analysis of variance, as well as χ² tests.
Results: The polymorphisms at IL-4Rα positions T1432C and A1652G were significantly associated with active VL infection. These results demonstrated that the IL-4Rα T1432C and A1652G polymorphisms were not associated with anti-Leishmania antibody production.
Conclusion: Our results indicate that these IL-4Rα polymorphisms may be risk factors for the development of V

Keywords

References

1.	Singh S. New developments in diagnosis of leishmaniasis. Indian J Med Res 2006;123:311-30. [PUBMED]
2.	Newlove T, Robinson M, Meehan SA, Pomerantz R. Old World cutaneous leishmaniasis. Dermatol Online J 2012;18:32.
3.	Ali N, Mekuria AH, Requena JM, Engwerda C. Immunity to visceral leishmaniasis. J Trop Med 2012;2012:780809.
4.	Jabara HH, Ahern DJ, Vercelli D, Geha RS. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J Immunol 1991;147:1557-60.
5.	Kazemi Arababadi M. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy. Iran J Kidney Dis 2010;4:302-6.
6.	Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2001;2:1054-60.
7.	Noben-Trauth N. Susceptibility to Leishmania major infection in the absence of IL-4. Immunol Lett 2000;75:41-4.
8.	Noben-Trauth N, Kropf P, Müller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996;271:987-90.
9.	Gama ME, Costa JM, Pereira JC, Gomes CM, Corbett CE. Serum cytokine profile in the subclinical form of visceral leishmaniasis. Braz J Med Biol Res 2004;37:129-36.
10.	Habibi GR, Khamesipour A, McMaster WR, Mahboudi F. Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR. Scand J Immunol 2001;54:414-20.
11.	Woitsch B, Carr D, Stachel D, Schmid I, Weiland SK, Fritzsch C, et al. A comprehensive analysis of interleukin-4 receptor polymorphisms and their association with atopy and IgE regulation in childhood. Int Arch Allergy Immunol 2004;135:319-24.
12.	Mohebali M, Javadian E, Yaghoobi-Ershadi MR, Akhavan AA, Hajjaran H, Abaei MR. Characterization of Leishmania infection in rodents from endemic areas of the Islamic Republic of Iran. East Mediterr Health J 2004;10:591-9.
13.	Oshaghi MA, Ravasan NM, Hide M, Javadian EA, Rassi Y, Sadraei J, et al. Phlebotomus perfiliewi transcaucasicus is circulating both Leishmania donovani and L. infantum in northwest Iran. Exp Parasitol 2009;123:218-25.
14.	Oshaghi MA, Ravasan NM, Javadian EA, Mohebali M, Hajjaran H, Zare Z, et al. Vector incrimination of sand flies in the most important visceral leishmaniasis focus in Iran. Am J Trop Med Hyg 2009;81:572-7.
15.	Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
16.	Bhattacharya P, Ali N. Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis. Rev Soc Bras Med Trop 2013;46:128-34.
17.	Costa AS, Costa GC, Aquino DM, Mendonça VR, Barral A, Barral-Netto M, et al. Cytokines and visceral leishmaniasis: A comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis. Mem Inst Oswaldo Cruz 2012;107:735-9.
18.	Rai AK, Thakur CP, Singh A, Seth T, Srivastava SK, Singh P, et al. Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis. PLoS One 2012;7:e31551.
19.	Mohamed HS, Ibrahim ME, Miller EN, Peacock CS, Khalil EA, Cordell HJ, et al. Genetic susceptibility to visceral leishmaniasis in The Sudan: Linkage and association with IL4 and IFNGR1. Genes Immun 2003;4:351-5.
20.	Cabantous S, Poudiougou B, Oumar AA, Traore A, Barry A, Vitte J, et al. Genetic evidence for the aggravation of Plasmodium falciparum malaria by interleukin 4. J Infect Dis 2009;200:1530-9.
21.	Vafa M, Maiga B, Berzins K, Hayano M, Bereczky S, Dolo A, et al. Associations between the IL-4 -590 T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali. Microbes Infect 2007;9:1043-8.
22.	Flórez O, Martín J, González CI. Interleukin 4, interleukin 4 receptor-a and interleukin 10 gene polymorphisms in Chagas disease. Parasite Immunol 2011;33:506-11.

Advanced Biomedical Research